Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 21

Trial Status

Terminated1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Research Network

Collaboration Network

19 collaborators·65 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

London Health Sciences Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

E-mail: ClinicalTrials@ ImClone.com

Eli Lilly and Company

Moderately Similar
22 trials

Shared therapeutic areas:

Ovary CancerPeritoneal Neoplasms
Similarity Score30%

C. William Helm, MD

James Graham Brown Cancer Center

Related
2 trials

Shared therapeutic areas:

Ovary CancerPeritoneal Neoplasms

Worked with same sponsors:

BiogenFacet Biotech
Collaborated on 1 trial
Similarity Score24%

Dana Glenn, MD

Sharp Hospital

Related
1 trials

Shared therapeutic areas:

Ovary CancerPeritoneal Neoplasms

Worked with same sponsors:

BiogenFacet Biotech
Collaborated on 1 trial
Similarity Score24%

Michael Gold, MD

Oklahoma University Health Science Center

Related
1 trials

Shared therapeutic areas:

Ovary CancerPeritoneal Neoplasms

Worked with same sponsors:

BiogenFacet Biotech
Collaborated on 1 trial
Similarity Score24%

Ernst Lengyel, MD

University of Chicago

Related
1 trials

Shared therapeutic areas:

Ovary CancerPeritoneal Neoplasms

Worked with same sponsors:

BiogenFacet Biotech
Collaborated on 1 trial
Similarity Score24%

Robert Holloway, MD

Florida Hospital Cancer Institute

Related
1 trials

Shared therapeutic areas:

Ovary CancerPeritoneal Neoplasms

Worked with same sponsors:

BiogenFacet Biotech
Collaborated on 1 trial
Similarity Score24%

Krish Tewari, MD

UCI Medical Center

Related
1 trials

Shared therapeutic areas:

Ovary CancerPeritoneal Neoplasms

Worked with same sponsors:

BiogenFacet Biotech
Collaborated on 1 trial
Similarity Score24%

John Glaspy, MD

University of California, Los Angeles

Related
1 trials

Shared therapeutic areas:

Ovary CancerPeritoneal Neoplasms

Worked with same sponsors:

BiogenFacet Biotech
Collaborated on 1 trial
Similarity Score24%

John Glaspy, MD

UCLA JCCC Clinical Research Unit

Related
1 trials

Shared therapeutic areas:

Ovary CancerPeritoneal Neoplasms

Worked with same sponsors:

BiogenFacet Biotech
Collaborated on 1 trial
Similarity Score24%

Michael Sawyer, MD

Cross Cancer Institute

Related
1 trials

Shared therapeutic areas:

Ovary CancerPeritoneal Neoplasms

Worked with same sponsors:

BiogenFacet Biotech
Collaborated on 1 trial
Similarity Score24%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00516841Phase 2PrincipalInvestigator

A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer

Ovarian CancerPeritoneal Neoplasms
Terminated

All 1 trials loaded